Rep. Daniel S. Goldman bought Centene (CNC)
Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Jan 31, 2023
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Jan 31, 2023
- Disclosed
- Feb 24, 2023
- Days to disclose
- 24
- Asset type
- Stock
- As filed
- Centene Corporation
- Industry
- Medical - Healthcare Plans · Healthcare
Other trades in this filing
All of Goldman's trades →- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
Sold (partial) Wheaton Precious Metals WPM
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
Bought Verizon Communications VZ
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
Got $1K from the company’s PAC - Feb 24, 2023$50K–$100K
- Feb 24, 2023$15K–$50K
Sold (partial) UnitedHealth Group UNH
$15K–$50K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
Bought United Airlines Holdings UAL
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$50K–$100K
Sold (partial) Union Pacific UNP
$50K–$100K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$15K–$50K
$15K–$50K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$100K–$250K
$100K–$250K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$1K–$15K
Sold (partial) ShockWave Medical SWAV
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$15K–$50K
Bought The Sherwin-Williams Company SHW
$15K–$50K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 24, 2023$15K–$50K
Sold Seacoast Banking Corporation of Florida SBCF
$15K–$50K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
Recent Congress trades in CNC
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Aug 8, 2025 · disclosed Jan 13, 2026 · filed 158 days later
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Apr 14, 2025 · disclosed Jan 13, 2026 · filed 274 days later
- Sep 12, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 5, 2025 · disclosed Sep 12, 2025
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
- Sep 3, 2025$100K–$250K
- Sep 3, 2025$1K–$15K
- Sep 3, 2025$15K–$50K
Company context for CNC
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure
The Department is issuing a final regulation that will require providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services to disclose information about their compensation to fiduciaries of large, self-insured group health plans subject to the Employee Retirement Income Security Act (ERISA). Pharmacy spending is a major driver of overall healthcare costs for employers and is growing faster than medical and surgical spending. These disclosure requirements apply for purposes of ERISA's statutory prohibited transaction exemption for service arrangements under section 408(b)(2). These disclosures are needed so that fiduciaries can assess the reasonableness of contracts or arrangements with these service providers, including the reasonableness of the service providers' compensation. As directed in section 12 of President Trump's Executive Order 14273, Lowering Drug Prices by Once Again Putting Americans First, the Department is issuing this rule to improve employer health plan transparency into the direct and indirect compensation received by pharmacy benefit managers. This final rule will affect sponsors and other fiduciaries of large, self-insured group health plans and certain service providers to such plans.
CNC: Financial results
Filed 8-K for an event or period dated 2026-10-27. Financial results.
CNC: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.